Genetic neurological channelopathies

Nature Clinical Practice Neurology

Volumn 2, Issue 5, 2006, Pages 252-263

  Hanna, Michael G ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Ataxia; Genetic channelopathy; Migraine; Myotonia; Paralysis

Indexed keywords

ACETAZOLAMIDE; CALCIUM CHANNEL; CALCIUM CHANNEL L TYPE; CARBOHYDRATE; CHLORIDE CHANNEL; DICLOFENAMIDE; GLYCINE RECEPTOR; ION CHANNEL; NICOTINIC RECEPTOR; POTASSIUM CHANNEL; RYANODINE RECEPTOR; SALBUTAMOL; SODIUM CHANNEL; THIAZIDE DIURETIC AGENT;

ATAXIA; BRAIN ELECTROPHYSIOLOGY; BRAIN FUNCTION; CELL FUNCTION; CEREBELLUM DISEASE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; EPILEPSY; FAMILIAL HEMIPLEGIC MIGRAINE; GENE MUTATION; GENETIC CODE; GENETIC DISORDER; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HEART ARRHYTHMIA; HEREDITY; HUMAN; HYPOKALEMIC PERIODIC PARALYSIS; IN VITRO STUDY; INHERITANCE; MIGRAINE; MOLECULAR GENETICS; MUSCLE DISEASE; MYOTONIA; MYOTONIC DYSTROPHY; NERVE CELL; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PERIODIC PARALYSIS; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE; THOMSEN DISEASE; TISSUE SPECIFICITY; TREATMENT PLANNING;

HUMANS; ION CHANNELS; MUTATION; NERVOUS SYSTEM DISEASES;

EID: 33646243805     PISSN: 1745834X     EISSN: 17458358     Source Type: Journal    
DOI: 10.1038/ncpneuro0178     Document Type: Review

References (66)

1. Kullmann DM and Hanna MG (2002) Neurological disorders caused by inherited ion-channel mutations. Lancet Neurol 1: 157-166
2. Graves TD and Hanna MG (2005) Neurological channelopathies. Postgrad Med J 81: 20-32
3. Jiang et al. (2003) X-ray structure of a voltage dependant potassium channel. Nature 423: 33-48
4. Ptacek LJ et al. (1992) Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita. Neuron 8: 891-897
5. Fontaine B et al. (1990) Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene. Science 250: 1000-1002
6. + channel α-subunit in hyperkalaemic periodic paralysis. Nature 354: 387-389
7. Jurkat-Rott K et al. (1994) A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet 3: 1415-1419
8. Ptacek LJ et al. (1991) Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 67: 1021-1027
9. Ptacek LJ et al. (1994) Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis. Neurology 44: 1500-1503
10. Ptacek LJ et al. (1994) Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77: 863-868
11. Plaster NM et al. (2001) Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 105: 511-519
12. Koch MC et al. (1992) The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 257: 797-800
13. Kubisch C et al. (1998) CIC-1 chloride channel mutations in myotonia congenita: Variable penetrance of mutations shifting the voltage dependence. Hum Mol Genet 7: 1753-1760
14. Wu FF et al. (2002) Novel CLCN1 mutations with unique clinical and electrophysiological consequences. Brain 125: 2392-2407
15. Bendahhou S et al. (1999) Activation and inactivation of the voltage-gated sodium channel: Role of segment S5 revealed by a novel hyperkalaemic periodic paralysis mutation. J Neurosci 19: 4762-4771
16. Hayward LJ et al. (1999) Defective slow inactivation of sodium channels contributes to familial periodic paralysis. Neurology 52: 1447-1453
17. Lehmann-Horn F et al. (1987) Adynamia episodica hereditaria with myotonia: A non-inactivating sodium current and the effect of extracellular pH. Muscle Nerve 10: 363-374
18. Hanna MG et al. (1998) Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A). J Neurol Neurosurg Psychiatry 65: 248-250
19. Hoskins B et al. (1975) Hyperkalemic periodic paralysis: Effects of potassium, exercise, glucose, and acetazolamide on blood chemistry. Arch Neurol 32: 519-523
20. Davies NP et al. (2000) Clinical, electrophysiological, and molecular genetic studies in a new family with paramyotonia congenita. J Neurol Neurosurg Psychiatry 68: 504-507
21. Weckbecker K et al. (2000) Different effects of mexiletine on two mutant sodium channels causing paramyotonia congenita and hyperkalemic periodic paralysis. Neuromuscul Disord 10: 31-39
22. Ricker K et al. (1994) Myotonia fluctuans: A third type of muscle sodium channel disease. Arch Neurol 51: 1095-1102
23. Cannon SC (1996) Sodium channel defects in myotonia and periodic paralysis. Ann Rev Neurosci 19: 141-164
24. Bulman DE et al. (1999) A novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology 53: 1932-1936
25. Davies NP et al. (2001) Sodium channel gene mutations in hypokalemic periodic paralysis: An uncommon cause in the UK. Neurology 57: 1323-1325
26. Sternberg D et al. (2001) Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain 124: 1091-1099
27. Jurkat-Rott K et al. (2000) Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci USA 97: 9549-9554
28. Elbaz A et al. (1995) Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): Genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families. Am J Hum Genet 56: 374-378
29. Chinnery PF et al. (2002) Normokalemic periodic paralysis revisited: does it exist? Ann Neurol 52: 251-252
30. Vicart S et al. (2004) New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis. Neurology 63: 2120-2127
31. Sansone V et al. (1997) Andersen's syndrome: A distinct periodic paralysis. Ann Neurol 42: 305-312
32. Davies NP et al. (2005) Andersen Tawil syndrome: New potassium channel mutations and possible phenotypic variation. Neurology 65: 1083-1089
33. Tristani-Firouzi M et al. (2002) Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 110: 381-388
34. Junker J et al. (2002) Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome. Neurology 59: 466
35. Dutzler R et al. (2002) X-ray structure of a CIC chloride channel at 3.0 Å reveals the molecular basis of ion selectivity. Nature 415: 287-294
36. Charlet-B N et al. (2002) Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 10: 45-53
37. Fournier E et al. (2004) Electromyography guides toward subgroups of mutations in muscle channelopathies. Ann Neurol 56: 650-661
38. Mulley JC et al. (2005) Susceptibility genes for complex epilepsy. Hum Mol Genet 14 (Suppl 2): SR243-SR249
39. Alekov A et al. (2001) Enhanced inactivation and acceleration of activation of the sodium channel associated with epilepsy in man. Eur J Neurosci 13: 2171-2176
40. Claes L et al. (2001) De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 68: 1327-1332
41. Escayg A et al. (2002) Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 24: 343-345
42. +-channel β1 subunit gene SCN1B. Nat Genet 19: 366-370
43. Biervert C et al. (1998) A potassium channel mutation in neonatal human epilepsy. Science 279: 403-406
44. Charlier C et al. (1998) A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 18: 53-55
45. Singh NA et al. (1998) A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 18: 25-29
46. De Fusco M et al. (2000) The nicotinic receptor β2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat Genet 26: 275-276
47. Steinlein OK et al. (1995) A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 11: 201-203
48. Haug K et al. (2003) Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nat Genet 33: 527-532
49. Zuberi SM et al. (1999) A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy. Brain 122: 817-825
50. Jouvenceau et al. (2001) Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 358: 801-807
51. v1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc Natl Acad Sci USA 98: 6384-6389
52. Sugawara T et al. (2002) Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy. Neurology 58: 1122-1124
53. Meisler MH and Kearney JA (2005) Sodium channel mutations in epilepsy and other neurological disorders. J Clin Invest 115: 2010-2017
54. Browne DL et al. (1994) Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1. Nat Genet 8: 136-140
55. Adelman JP et al. (1995) Episodic ataxia results from voltage-dependent potassium channels with altered functions. Neuron 15: 1449-1454
56. + channel subunit dysfunction in inherited mutations of KCNA1. J Physiol 538: 5-23
57. Herson PS (2003) et al. A mouse model of episodic ataxia type-1. Nat Neurosci 6: 378-383
58. Eunson LH et al. (2000) Clinical, genetic, and expression studies of mutations in the potassium channel gene KCNA1 reveal new phenotypic variability. Ann Neurol 48: 647-656
59. 2+ channel gene CACNL1A4. Cell 87: 543-552
60. v2.1 in absence epilepsy and episodic ataxia. Brain 127: 2682-2692
61. Ducros A et al. (2001) The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med 345: 17-24
62. + pump α2 subunit associates with familial hemiplegic migraine type 2. Nat Genet 33: 192-196
63. Dichgans M et al. (2005) Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366: 371-377
64. v2.1 current density in neurons. Proc Natl Acad Sci USA 99: 13284-13289
65. 2+ channelopathy. Neuron 43: 387-400
66. van den Maagdenberg AM et al. (2004) A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41: 701-710